Summary of clinical findings in the R1193Q carriers
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |
|---|---|---|---|---|---|---|---|---|---|
| *Indicated negative findings. | |||||||||
| †Type 1∼3 ST segment abnormalities in leads V1–V3.[3] | |||||||||
| ‡Normal <440 ms. | |||||||||
| F, female; M, male; VPC, ventricular premature complex. | |||||||||
| Genotype | R/Q | R/Q | R/Q | R/Q | R/Q | R/Q | R/Q | R/Q | Q/Q |
| Age/sex | 35, F | 32, M | 45, F | 40, F | 71, M | 26, M | 75, F | 46, M | 76, M |
| History of syncope or arrhythmia | –* | – | – | – | – | – | – | – | – |
| Family history of sudden death or arrhythmia | – | – | – | – | – | – | – | – | – |
| ECG findings | |||||||||
| Brugada sign† | – | – | – | – | – | – | – | – | – |
| QTc (ms)‡ | 367 | 395 | 427 | 422 | 367 | 364 | 472 | 418 | 437 |
| Others | Frequent VPCs | – | – | – | – | – | – | – | – |